Global decubitus ulcer treatment products demand is anticipated to be valued at US$ 4,989.4 million in 2023, forecast to grow at a CAGR of 5.5% to be valued at US$ 8,503.4 million from 2023 to 2033. The growth of the decubitus ulcer treatment products market is attributed to an increase in the geriatric population living with disabilities.
Decubitus ulcers are also known as bed sores or pressure sores. Decubitus ulcers are open wounds on the skin covering the bony area of the body. They are caused due to constant and unrelieved pressure due to lack of mobility and blood circulation. It can also be caused by friction between the skin and another surface, excessive moisture caused by perspiration, and urinary or fecal incontinence.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value (2023) | US$ 4,989.4 million |
| Anticipated Forecast Value (2033) | US$ 8,503.4 million |
| Projected Growth Rate (2023 to 2033) | 5.5% CAGR |
Bed sores can occur on any part of the body, though the common sites are hips, knees, elbows, ankles, buttocks, and shoulder blades. People who feel difficulty moving or changing their position and are lying in bed for extended periods are at high risk of developing bed sores. Growing incidences of chronic diseases and a rise in awareness regarding the availability of decubitus ulcer treatment products are also anticipated to propel the market for decubitus ulcer treatment products.
On the contrary, the high price of pressure ulcer relief products and the economic downturn are the major factors expected to restrain the growth of the decubitus ulcer treatment products market during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The aging population is considered one of the major factors expected to boost the growth of the Decubitus Ulcer Market during the forecast period. The market for decubitus ulcer treatment products is also witnessing the introduction of innovative mattresses and beds for treatment. The shift in trends toward home-based care is another factor fueling the demand for such durable products.
Increasing incidences of decubitus ulcers, technological advancements, government initiatives, and the development of imaging technologies to enable early detection of ulcers are other major factors expected to accelerate the growth of the decubitus ulcer treatment products market over the analysis period.
The increasing number of mergers and acquisitions, collaborations and partnerships, and product launches are some of the latest trends in the global decubitus ulcer treatment products market. This factor is also expected to augment the market's growth in the forthcoming years.
The high price of pressure ulcer relief products is one of the major factors that is expected to impede the market's growth during the forecast period. Additionally, the economic downturn is another major factor that is anticipated to limit the growth of the decubitus ulcer treatment products market over the analysis period.
Principal Consultant
Regarding regional platforms, North America holds the largest market share in the decubitus ulcer treatment products market. The region is expected to surge to over 37.6% share in 2023. The decubitus ulcer treatment products market in North America is primarily driven by product innovation and growing trends toward home-based care in the region. In addition, the largest incidence of pressure ulcers, improved healthcare infrastructure, and technological advancements are fueling the market growth in this region.
Factors such as a substantial rise in the geriatric population living with disabilities, a rapidly increasing prevalence of pressure ulcers, and the growing adoption of novel wound care devices for its treatment in the region are expected to augment the market growth during the forecast period.
According to the Agency for Healthcare Research & Quality (AHRQ), more than 2.5 million individuals are in the United States. Develop pressure ulcers annually. The increasing awareness about the availability of treatment options for P.U., the rise in healthcare expenditures, and an increase in advanced treatment procedures are anticipated to propel the pressure ulcer treatment market growth over the analysis period. Combined with this, a rise in the demand for multiple treatment options by patients diagnosed around the globe is likely to increase the pressure ulcer market size in the near future.
According to Future Market Insights, Europe is expected to hold significant growth opportunities for the decubitus ulcer treatment products market and is expected to reach a share of 29.0% in 2023.
Europe is expected to witness a high growth rate in the decubitus ulcer treatment products market in the next few years due to increasing demand for improved healthcare facilities, a rise in awareness regarding pressure ulcer treatment products, improved healthcare infrastructure, and an increasing patient population in the region.
The rising geriatric population and increasing prevalence of pressure ulcers are anticipated to drive the market in this region. Combined with this, higher treatment costs of pressure ulcers in countries such as Germany, France, and the UK are expected to create growth opportunities for the market in the forthcoming years.
For instance, in the UK, the cost of treatment of pressure ulcers to the NHS is estimated to be US$ 1.5 - US$ 2.4 billion annually, making pressure ulcers the single costliest chronic wound to the NHS.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
According to Future Market Insights, Asia-Pacific is expected to grow with lucrative growth opportunities for the decubitus ulcer treatment products market. It is expected to reach a significant share of 20.5% in 2023.
Asia Pacific is projected to register significant market growth during the forecast period, attributed to the rapidly increasing geriatric population and the growing patient pool of pressure ulcers in the region. For instance, the United Nations Population Fund (UNFPA) currently states that the geriatric population in Asia Pacific is rising at an unprecedented rate. It also states that by 2050, one in four people in this region will be above 60 years of age.
Growing populations and economies in developing countries such as India and China are expected to drive the growth of the Asia Pacific's decubitus ulcer treatment products market. In addition, innovations along with technological advancements, growing awareness regarding decubitus ulcer treatment products, rise in incidences of chronic disorders, and introduction of cost-effective pressure ulcer treatment products are expected to create new opportunities for the growth of the region's decubitus ulcer treatment products market.
Well-established healthcare infrastructure is also an important reason for the market growth in these regions. Economies such as India, China, and Japan are expected to play a key role in driving the market growth in Asia-Pacific. These markets are experiencing an increased penetration by companies operating in this market.
According to Future Market Insights, Middle East & Africa is expected to provide significant growth opportunities for the decubitus ulcer treatment products market. It is expected to reach a share of 11% in 2023.
The decubitus ulcer treatment products market in the Middle East & Africa is anticipated to witness lucrative growth during the forecast period, attributed to the rising awareness regarding the availability of treatment options for pressure ulcers and developing healthcare facilities.
Moreover, the increasing prevalence of pressure ulcers, improved healthcare facilities, increasing new launches of advanced technologies, and the high cost of products are the major factors that are expected to escalate the market growth in this region over the analysis period.
There are many prominent market players in the decubitus ulcer treatment products market, such as KroniKare, Piomic, Untech, Fibroheal Woundcare, RenovoDerm, and Bruin Biometrics, among others, that are working hand-in-hand to provide the best-in-class Decubitus Ulcer Treatment Products for enhancing the global arena. However, there are many global startups in the decubitus ulcer treatment products market who are stepping forward to match the requirements of the Decubitus Ulcer Treatment Products domain.
Some of the key participants present in the global Decubitus Ulcer Treatment Products market include Mölnlycke Health Care AB, ConvaTec Group Plc., B. Braun Melsungen AG, Coloplast Corp., Smith & Nephew, 3M, Integra LifeSciences Corporation, Cardinal Health, and Tissue Regenix, among others.
Due to the presence of such a high number of participants, the market is highly competitive. While global players such as Mölnlycke Health Care AB, ConvaTec Group Plc., B. Braun Melsungen AG, Coloplast Corp., and Smith & Nephew account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in North America.
Recent Developments
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.5% from 2023 to 2033 |
| Base Year for Estimation | 2023 |
| Market Value in 2023 | US$ 4,989.4 million |
| Market Value in 2033 | US$ 8,503.4 million |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
This market is estimated to reach US$ 8,503.4 million by 2033.
The United States, India, and China dominate the global market.
The high price of pressure ulcer relief products is the factor challenging the industry.
The increasing number of mergers and acquisitions.
Asia Pacific is projected to emerge as a lucrative market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Depth of Soft Tissue Damage
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Depth of Soft Tissue Damage, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Depth of Soft Tissue Damage, 2023 to 2033
5.3.1. Stage I
5.3.2. Stage II
5.3.3. Stage III
5.3.4. Stage IV
5.4. Y-o-Y Growth Trend Analysis By Depth of Soft Tissue Damage, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Depth of Soft Tissue Damage, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
6.3.1. Hospitals Clinics
6.3.2. Public Hospitals
6.3.3. Private Clinics
6.3.4. Retail Pharmacies and Drug Stores
6.3.5. E-commerce
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Depth of Soft Tissue Damage
8.2.3. By Distribution Channel
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Depth of Soft Tissue Damage
8.3.3. By Distribution Channel
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Depth of Soft Tissue Damage
9.2.3. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Depth of Soft Tissue Damage
9.3.3. By Distribution Channel
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Depth of Soft Tissue Damage
10.2.3. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Depth of Soft Tissue Damage
10.3.3. By Distribution Channel
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Depth of Soft Tissue Damage
11.2.3. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Depth of Soft Tissue Damage
11.3.3. By Distribution Channel
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Depth of Soft Tissue Damage
12.2.3. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Depth of Soft Tissue Damage
12.3.3. By Distribution Channel
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Depth of Soft Tissue Damage
13.2.3. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Depth of Soft Tissue Damage
13.3.3. By Distribution Channel
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Depth of Soft Tissue Damage
14.2.3. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Depth of Soft Tissue Damage
14.3.3. By Distribution Channel
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Depth of Soft Tissue Damage
15.1.2.2. By Distribution Channel
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Depth of Soft Tissue Damage
15.2.2.2. By Distribution Channel
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Depth of Soft Tissue Damage
15.3.2.2. By Distribution Channel
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Depth of Soft Tissue Damage
15.4.2.2. By Distribution Channel
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Depth of Soft Tissue Damage
15.5.2.2. By Distribution Channel
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Depth of Soft Tissue Damage
15.6.2.2. By Distribution Channel
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Depth of Soft Tissue Damage
15.7.2.2. By Distribution Channel
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Depth of Soft Tissue Damage
15.8.2.2. By Distribution Channel
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Depth of Soft Tissue Damage
15.9.2.2. By Distribution Channel
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Depth of Soft Tissue Damage
15.10.2.2. By Distribution Channel
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Depth of Soft Tissue Damage
15.11.2.2. By Distribution Channel
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Depth of Soft Tissue Damage
15.12.2.2. By Distribution Channel
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Depth of Soft Tissue Damage
15.13.2.2. By Distribution Channel
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Depth of Soft Tissue Damage
15.14.2.2. By Distribution Channel
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Depth of Soft Tissue Damage
15.15.2.2. By Distribution Channel
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Depth of Soft Tissue Damage
15.16.2.2. By Distribution Channel
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Depth of Soft Tissue Damage
15.17.2.2. By Distribution Channel
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Depth of Soft Tissue Damage
15.18.2.2. By Distribution Channel
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Depth of Soft Tissue Damage
15.19.2.2. By Distribution Channel
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Depth of Soft Tissue Damage
15.20.2.2. By Distribution Channel
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Depth of Soft Tissue Damage
15.21.2.2. By Distribution Channel
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Depth of Soft Tissue Damage
15.22.2.2. By Distribution Channel
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Depth of Soft Tissue Damage
15.23.2.2. By Distribution Channel
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Depth of Soft Tissue Damage
16.3.3. By Distribution Channel
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Hill-Rom Company Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Graham Field Health Products Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Invacare Corporation
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Sunrise Medical Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. ROHO Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Kinetic Concepts Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Span-America Medical Systems Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Spenco Medical Corp
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Cardinal Health
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Smith & Nephew
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Decubitus Ulcer Treatment Products Market
